未找到相关数据
A prospective, randomized, double-blinded, placebo controlled, phase III study to evaluate the efficacy and safety of apatinib plus best supportive care (BSC) compared to placebo plus BSC in patients with advanced or metastatic gastric cancer: The ANGEL study.
被引：5
作者：
Kang, Yoon-Koo
Boku, Narikazu
Kang, Won Ki
Yoon, Harry H.
Cascinu, Stefano
Al-Batran, Salah-Eddin
Houston, Scott
Park, Cheol Hee
机构：
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.TPS4138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4138
引用
收藏
页数：5
相关论文